Cargando…
Effectiveness of fourth-line dual immunotherapy in hepatocellular carcinoma with simultaneous steroid administration for immune-related hepatitis
Medical therapy of advanced hepatocellular carcinoma (HCC) remains an emerging subject, but therapeutic sequences together with toxicity management are rarely described. Herein, we report the case of a therapeutic sequence and toxicity management in a 72-year old White male with advanced non-cirrhot...
Autores principales: | Lowes, Kristina, Reinecke, Johanna, Brunner, Marius, Scholz, Matthias, Kitz, Julia, Michels, Beate, Mekolli, Ardian, Gaedcke, Jochen, Seif Amir Hosseini, Ali, Ströbel, Philipp, Ghadimi, Michael, Ellenrieder, Volker, Koenig, Alexander, Koenig, Ute |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844730/ https://www.ncbi.nlm.nih.gov/pubmed/35178123 http://dx.doi.org/10.1177/17562848211051026 |
Ejemplares similares
-
Cure Is Possible: Extensively Metastatic HER2-Positive Gastric Carcinoma with 5 years of Complete Remission after Therapy with the FLOT Regimen and Trastuzumab
por: Schade, Sebastian, et al.
Publicado: (2022) -
Brain metastases in gastroesophageal cancers—an underestimated complication
por: Brunner, Marius, et al.
Publicado: (2021) -
Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated KRAS in Regulating Cellular Plasticity and Gemcitabine Response in Pancreatic Adenocarcinomas
por: Peng, Luogen, et al.
Publicado: (2023) -
Epigenome Mapping Identifies Tumor-Specific Gene Expression in Primary Rectal Cancer
por: Flebbe, Hannah, et al.
Publicado: (2019) -
Heterogeneity of KRAS Mutation Status in Rectal Cancer
por: Jo, Peter, et al.
Publicado: (2016)